Intramedullary Megakaryocytes Internalize Released Platelet Factor 4 and Store It in Alpha Granules

Overview

Journal J Thromb Haemost

Publisher Elsevier

Specialty Hematology

Date 2015 Aug 11

PMID 26256688

Citations 15

Authors

M P Lambert

R Meng

L Xiao

D C Harper

M S Marks

M A Kowalska

M Poncz

Affiliations

Soon will be listed here.

Abstract

Background: Megakaryocytes express and store platelet factor 4 (PF4) in alpha granules. In vivo, PF4 is a clinically relevant, negative regulator of megakaryopoiesis and hematopoietic stem cell replication. These findings would suggest a regulated source of free intramedullary PF4.

Objectives: Define the source of free intramedullary PF4 and its intramedullary life cycle.

Methods: We interrogated both murine and human bone marrow-derived cells during megakaryopoiesis in vitro by using confocal microscopy and enzyme-linked immunosorbent assay. With immunohistochemistry, we examined in vivo free PF4 in murine bone marrow before and after radiation injury and in the setting of megakaryocytopenia and thrombocytopenia.

Results: Exogenously added human PF4 is internalized by murine megakaryocytes. Human megakaryocytes similarly take up murine PF4 but not the related chemokine, platelet basic protein. Confocal microscopy shows that internalized PF4 colocalizes with endogenous PF4 in alpha granules and is available for release on thrombin stimulation. Immunohistochemistry shows free PF4 in the marrow, but not another alphagranule protein, von Willebrand factor. Free PF4 increases with radiation injury and decreases with megakaryocytopenia. Consistent with the known role of low-density lipoprotein receptor-related protein 1 in the negative paracrine effect of PF4 on megakaryopoiesis, PF4 internalization is at least partially low-density lipoprotein receptor-related protein 1 dependent.

Conclusions: PF4 has a complex intramedullary life cycle with important implications in megakaryopoiesis and hematopoietic stem cell replication not seen with other tested alpha granule proteins.

Citing Articles

Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow.

Lykins J, Becker I, Camacho V, Alfar H, Park J, Italiano J Blood Adv. 2024; 9(1):15-28.

PMID: 38941534 PMC: 11732581. DOI: 10.1182/bloodadvances.2024012995.

The many faces of the megakaryocytes and their biological implications.

Guo K, Machlus K, Camacho V Curr Opin Hematol. 2023; 31(1):1-5.

PMID: 37910197 PMC: 10842450. DOI: 10.1097/MOH.0000000000000793.

Megakaryocyte Secreted Factors Regulate Bone Marrow Niche Cells During Skeletal Homeostasis, Aging, and Disease.

Karnik S, Nazzal M, Kacena M, Bruzzaniti A Calcif Tissue Int. 2023; 113(1):83-95.

PMID: 37243755 PMC: 11179715. DOI: 10.1007/s00223-023-01095-y.

Benzo[a]pyrene Exposure Reduces Cell-Type Diversity and Stimulates Sex-Biased Damage Pathways in End Organs of Lupus-Prone Mice.

Zhu R, Kennicott K, Liang Y Int J Mol Sci. 2023; 24(7).

PMID: 37047136 PMC: 10093912. DOI: 10.3390/ijms24076163.

FLAN: feature-wise latent additive neural models for biological applications.

Nguyen A, Vasilaki S, Rodriguez Martinez M Brief Bioinform. 2023; 24(3).

PMID: 37031956 PMC: 10199769. DOI: 10.1093/bib/bbad056.

References

Saenko E, Yakhyaev A, Mikhailenko I, Strickland D, Sarafanov A . Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem. 1999; 274(53):37685-92. DOI: 10.1074/jbc.274.53.37685. View

Naldini L, Blomer U, Gage F, Trono D, Verma I . Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996; 93(21):11382-8. PMC: 38066. DOI: 10.1073/pnas.93.21.11382. View

Zhang C, Thornton M, Kowalska M, Sachis B, Feldman M, Poncz M . Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus. Blood. 2001; 98(3):610-7. DOI: 10.1182/blood.v98.3.610. View

Eslin D, Zhang C, Samuels K, Rauova L, Zhai L, Niewiarowski S . Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood. 2004; 104(10):3173-80. DOI: 10.1182/blood-2003-11-3994. View

Bouchard B, Williams J, Meisler N, Long M, Tracy P . Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost. 2005; 3(3):541-51. DOI: 10.1111/j.1538-7836.2005.01190.x. View

Buch T, Heppner F, Tertilt C, Heinen T, Kremer M, Wunderlich F . A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods. 2005; 2(6):419-26. DOI: 10.1038/nmeth762. View

El Golli N, Issertial O, Rosa J, Briquet-Laugier V . Evidence for a granule targeting sequence within platelet factor 4. J Biol Chem. 2005; 280(34):30329-35. DOI: 10.1074/jbc.M503847200. View

Ceresa B . Regulation of EGFR endocytic trafficking by rab proteins. Histol Histopathol. 2006; 21(9):987-93. DOI: 10.14670/HH-21.987. View

Tiedt R, Schomber T, Hao-Shen H, Skoda R . Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 2006; 109(4):1503-6. DOI: 10.1182/blood-2006-04-020362. View

10.

Lambert M, Rauova L, Bailey M, Sola-Visner M, Kowalska M, Poncz M . Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications. Blood. 2007; 110(4):1153-60. PMC: 1976471. DOI: 10.1182/blood-2007-01-067116. View

11.

Sehgal S, Storrie B . Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost. 2007; 5(10):2009-16. DOI: 10.1111/j.1538-7836.2007.02698.x. View

12.

Blair P, Flaumenhaft R . Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009; 23(4):177-89. PMC: 2720568. DOI: 10.1016/j.blre.2009.04.001. View

13.

Lambert M, Wang Y, Bdeir K, Nguyen Y, Kowalska M, Poncz M . Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes. Blood. 2009; 114(11):2290-8. PMC: 2745847. DOI: 10.1182/blood-2009-04-216473. View

14.

Kowalska M, Rauova L, Poncz M . Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res. 2009; 125(4):292-6. DOI: 10.1016/j.thromres.2009.11.023. View

15.

Zingariello M, Fabucci M, Bosco D, Migliaccio A, Martelli F, Rana R . Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation. Biotech Histochem. 2010; 85(3):157-70. PMC: 3700322. DOI: 10.3109/10520290903149612. View

16.

Katsman Y, Foo A, Leontyev D, Branch D . Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction. Transfusion. 2010; 50(6):1285-94. DOI: 10.1111/j.1537-2995.2009.02558.x. View

17.

Venneti S, Le P, Martinez D, Eaton K, Shyam N, Jordan-Sciutto K . p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol. 2011; 70(7):596-609. PMC: 3145456. DOI: 10.1097/NEN.0b013e31822146ca. View

18.

Lambert M, Xiao L, Nguyen Y, Kowalska M, Poncz M . The role of platelet factor 4 in radiation-induced thrombocytopenia. Int J Radiat Oncol Biol Phys. 2011; 80(5):1533-40. PMC: 3134787. DOI: 10.1016/j.ijrobp.2011.03.039. View

19.

Suzuki-Inoue K . Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. J Biochem. 2011; 150(2):127-32. DOI: 10.1093/jb/mvr079. View

20.

Blavignac J, Bunimov N, Rivard G, Hayward C . Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost. 2011; 37(6):713-20. DOI: 10.1055/s-0031-1291382. View